PlainRecalls
FDA Drug Moderate Class II Ongoing

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.

Reported: May 21, 2025 Initiated: March 5, 2025 #D-0417-2025

Product Description

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.

Reason for Recall

Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

Details

Recalling Firm
L'Oreal USA
Units Affected
2,226,801 bottles
Distribution
Nationwide in the USA
Location
Clark, NJ

Frequently Asked Questions

What product was recalled?
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.. Recalled by L'Oreal USA. Units affected: 2,226,801 bottles.
Why was this product recalled?
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 21, 2025. Severity: Moderate. Recall number: D-0417-2025.